Necro from someone that was active in the 00s... I've got a lot of hair, don't shed on tren or deca, but I lost about 25% by volume on a 12-week of 11-OXO spray (Prototype). Love the cycle but never again.
I'm in Tokyo for six months and just got my two boxes (60 tabs) shipped to me. I'm not going to have time to log it, but I'll give me opinions at cycle-end. Glad to see that this board is still around.
It looks as though you've lost <10% or so. Ask PA to file a claim with the carrier and get a refund for the shipping, which should cover the amount you've lost. Looks like 3 days worth of product.
It was featured on one of the workout channels (FitTV, etc.) with an female Olympic swimmer. The company and gym were based out of L.A. The machines were used for one set, as many reps as could be completed in 20-30 seconds. There was feedback on each set analyzed by software. Chris Chelios was...
How does it taste? I agree that Xtend tastes so good, relative to what's out there, that I don't trust the label. BCAA formulations uniformly taste like sh*t.
s
lol purple wraath. I don't think I've taken a product that tastes more foul. Wait, LG's BCAA may be even less palatable. I had high hopes for PW, but will stick with Xtend Grape + Ajipure.
I do know that Sirtis/GSK use a micronized product. Their first true success was with micronized resveratrol and tween. The highest plasma conc were achieved by Sirtis with micronized resveratrol.
I'll concede that I probably know as much about SEDDS as you know about what is best-practice...
Sirtis uses micronized resveratrol in its SRT501 compound. Also, I am sure you've seen the Westphal data:
Invalid Link Removed
600mg/kg resveratrol
500mg/kg micronized resveratrol, no carrier
400mg/kg micronized resveratrol, DOSS+HPMC
A > 2x plasma conc. on micronized over standard particle...
I am not producing supplements, so I use PEG3350 (Miralax) and Polysorbate80. I've used F50 HPMC as well. PEG 8xxx or better would be advised.
Sirtis doesn't use a SEDDS, and achieved much higher plasma concentrations then the journal-data you provide. You have no empirical data that you...
I wouldn't consider undertaking a biz opportunity with such a small potential market, and it's outside of my line of work as a CDS/variance-swap dealer. One of my points is that PP is missing an opportunity in pricing it outside the EOD.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.